Soluble Interleukin-6 Receptor α Inhibits the Cytokine-Induced Fractalkine/CX3CL1 Expression in Human Vascular Endothelial Cells in Culture
- 10 September 2001
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 269 (1), 35-41
- https://doi.org/10.1006/excr.2001.5300
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- ChemokinesImmunity, 2000
- Expression of Tumor Necrosis Factor-α in Cultured Human Endothelial Cells Stimulated With Lipopolysaccharide or Interleukin-1αArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Interferon-γ Stimulates the Expression of CX3CL1/Fractalkine in Cultured Human Endothelial CellsThe Tohoku Journal of Experimental Medicine, 2000
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997
- Lymphocyte Adhesion to EndotheliumCritical Reviews in Immunology, 1995
- Lymphocyte interactions with endothelial cellsImmunology Today, 1992
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990
- Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytesCell, 1989
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989